Trader’s Alert: Teva Pharmaceutical Industries (NYSE:TEVA), Forest Laboratories (NYSE:FRX), Auxilium Pharmaceuticals (NASDAQ:AUXL), ProPhase Labs (NASDAQ:PRPH)

The US units of generic drug firms Ranbaxy Laboratories Ltd and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) have agreed to pay a total of $30,000 to the state of New York to settle claims that an agreement between the two drug makers unlawfully restricted competition. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened at $46.47 in last session, and closed at $48.20, while the day range of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is $46.42 – $49.23. The stock showed a positive weekly performance of 9.37%.

Forest Laboratories Inc. (NYSE:FRX) was upgraded by stock analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report issued on Tuesday, StockRatingsNetwork reports. Forest Laboratories, Inc. (NYSE:FRX) stock opened at $93.85 in last session, and closed at $97.30 by gaining 3.53%. The 52 week range of $35.22 – $97.97. Company’s market capitalization is $26.22B.

Shares of Auxilium Pharmaceuticals (NASDAQ:AUXL) have received a consensus rating of “Buy” from the seventeen analysts that are presently covering the stock, American Banking News reports. Five analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company.

Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) stock increased 3.19% and finished the last session at $29.07. The EPS of the stock remained 2.23. Company’s market capitalization is $1.44B.

ProPhase Labs, Inc. (NASDAQ:PRPH) is a manufacturer, marketer and distributor of a ranges of homeopathic and health products that are offered to the general public. The Company is also engaged in the research and development of potential over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. ProPhase Labs Inc. (NASDAQ:PRPH) stock opened the session at $2.04, and closed the session at $2.09. The 52 week range of the ProPhase Labs Inc. (NASDAQ:PRPH) stock remained $1.41 – $2.98 and the day range was $1.98 – $2.10.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *